D. Hu

Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer

Gang Chen, W. Zhuang, G. Lin, 2022, Radiation Oncology.

A nomogram-based overall survival stratification to identify uterine sarcoma patients without distant metastases who may benefit from adjuvant radiotherapy.

Ruifen He, Chang Liu, Xiaolei Liang, 2022, Gynecologic oncology.

LBA43 GEMSTONE-301: A randomized, double-blind, placebo-controlled, phase III study of sugemalimab in patients with unresectable stage III non-small cell lung cancer (NSCLC) who had not progressed after concurrent or sequential chemoradiotherapy (CRT)

Q. Wang, N. Cui, Y. Wu, 2021, Annals of Oncology.

OA02.05 Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study

Y. Wu, Y. Cheng, M. Chen, 2022, Journal of Thoracic Oncology.

Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population.

A. Mansfield, L. Zeng, Chunhua Zhou, 2020, Lung cancer.

The influence of pemetrexed-based continuous maintenance therapy on survival of locally advanced and metastatic lung adenocarcinoma.

Gang Wu, Rui-guang Zhang, Ying Wang, 2019, Annals of translational medicine.